- Recent Funding
- Investors
- Frazier Life Sciences
Frazier Life Sciences portfolio
Frazier Life Sciences has 9 portfolio companies on record at Recent Funding, with 4 investments in the last 12 months.
About this page
It is a venture capital firm based in Palo Alto, US, founded in 2015. It led 6 of the 9 rounds it joined. Its most recent investment on record is RQ Bio's $115M Series A round in June 2026, which it led, alongside Forbion Capital Partners, EQT Life Sciences, Wellington Management and 4 others. By category, its portfolio leans toward Health and bio (9) and Logistics and mobility (1). It has co-invested with Longitude Capital, Nextech Invest and Janus Henderson Investors, most often Longitude Capital (3 rounds).
About Frazier Life Sciences
What Frazier Life Sciences invests in
- Health and bio · 9 · 100%
- Logistics and mobility · 1 · 11%
Frazier Life Sciences recent investments
| Company | Round | Date | Alongside |
|---|---|---|---|
| Series A · $115M · lead | Forbion Capital Partners, EQT Life Sciences, Wellington Management +4 | ||
| Series A · $86.45M · lead | Cambridge Innovation Capital, Qiming Venture Partners, Cambridge Enterprise Ventures +2 | ||
| Series A · $200M · lead | Longitude Capital, Goldman Sachs Alternatives, SR One +2 | ||
| Series B+ · $115M · lead | LYFE Capital, Kite Pharma, Lifeforce Capital +6 | ||
| Series B+ · $360M | Venrock Healthcare Capital Partners (lead), HTGF, Fund+ +6 | ||
| Series B+ · lead | Marshall Wace, Janus Henderson Investors, Deep Track Capital +6 | ||
| Series B+ · $175M | Digitalis Ventures, Janus Henderson Investors, Longitude Capital +6 | ||
| Series B+ · $138M | HTGF, EQT Life Sciences (lead), Fund+ +6 |
How Frazier Life Sciences invests
Frazier Life Sciences portfolio companies
RRQ Bio$115MSeries A · Jun 2026
IImmutrin$86.45MSeries A · Mar 2026
AAirNexis Therapeutics$200MSeries A · Jan 2026
AAspen Neuroscience$115MSeries B+ · Nov 2025
TTubulis$360MSeries B+ · Oct 2025335PharmaSeries B+ · Nov 2024
AAlpha-9 Oncology$175MSeries B+ · Oct 2024
LLassen Therapeutics$85MSeries B+ · Jan 2024
AAngitia Biobacker
| Company | Round with Frazier Life Sciences | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Series A · $115M · lead | $115M | Jun 24, 2026 Series A |
Health and bio |
Series A · $86.45M · lead | $86.45M | Mar 26, 2026 Series A |
Health and bio |
Series A · $200M · lead | $200M | Jan 9, 2026 Series A |
Health and bio |
Series B+ · $115M · lead | $339M | Nov 20, 2025 Series B+ |
Health and bio |
Series B+ · $360M | $573M | Oct 16, 2025 Series B+ |
Health and bio |
Series B+ · lead | undisclosed | Nov 26, 2024 Series B+ |
Health and bio |
Series B+ · $175M | $175M | Oct 23, 2024 Series B+ |
Health and bio |
Series B+ · $85M · lead | $116M | Jan 17, 2024 Series B+ |
Health and bio |
backer | $130M | Feb 12, 2026 Series B+ |
Most frequent co-investors
LLongitude Capital3 shared rounds · last Jan 9, 2026
NNextech Invest3 shared rounds · last Oct 16, 2025
JJanus Henderson Investors3 shared rounds · last Oct 16, 2025
EEQT Life Sciences2 shared rounds · last Jun 24, 2026
WWellington Management2 shared rounds · last Jun 24, 2026
SSR One2 shared rounds · last Mar 26, 2026
OOrbiMed2 shared rounds · last Jan 9, 2026
HHTGF2 shared rounds · last Oct 16, 2025
SSeventure Partners2 shared rounds · last Oct 16, 2025
FFund+2 shared rounds · last Oct 16, 2025
OOCCIDENT2 shared rounds · last Oct 16, 2025
DDeep Track Capital2 shared rounds · last Nov 26, 2024
Similar investors
BBusiness Growth Fund9 companies · 4 deals in 12 mo
DDimension9 companies · 4 deals in 12 mo
FFrist Cressey Ventures9 companies · 4 deals in 12 mo
LLegend Capital9 companies · 4 deals in 12 mo
TThe Venture Collective9 companies · 4 deals in 12 mo
GGenesis Capital VC9 companies · 3 deals in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Firm profile: Fundraising Fox Open Dataset v2026-11, CC BY 4.0. Track-record counts are theirs, not Recent Funding's.
Share is of the 9 rounds on Recent Funding that name Frazier Life Sciences. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists Frazier Life Sciences, which is a subset of its real portfolio. API: /api/v1/investors/frazier-life-sciences (get a free API key). More: the most active VC firms and new venture capital funds.
The week's top funded startups and market insights, in your inbox every Monday.
Unsubscribe anytime · privacy